Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention: 2025 (Advanced Bio-Medical CRISPR Technologies)

Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention This comprehensive book delves into the cutting-edge field of cancer vaccines, blending the power of immunotherapy with advanced genetic engineering to pioneer universal strategies for cancer prevention. It explores the identification of universal tumor antigens and the design of mRNA- and DNA-based vaccines that target key cancer mutations across diverse tumor types. Central to vaccine efficacy are dendritic cells and tumor-specific T-cell activation, which are enhanced through novel adjuvants, nanoparticle delivery systems, and CRISPR gene editing techniques. Personalized vaccines tailored to rare and common genetic mutations, hormone-sensitive cancers, hematologic malignancies, and pediatric tumors are discussed, emphasizing the importance of immune modulation and overcoming tumor evasion mechanisms. The integration of immune checkpoint inhibitors with vaccines amplifies immune responses and helps prevent metastasis and recurrence. Innovations such as viral vector and oncolytic virus-based vaccines, microneedle delivery, and combination therapies including CAR-T cells broaden the therapeutic landscape. The book also highlights clinical trial advancements, epigenetic vaccine enhancement, and strategies to induce long-term immunity. By addressing tumor heterogeneity, immune tolerance, and the tumor microenvironment, this work presents a roadmap toward the development of broad-spectrum and personalized cancer vaccines. It is an essential resource for researchers and clinicians aiming to harness genetic and immune-based tools to transform cancer prevention and treatment on a universal scale.